METRONIDAZOLE 1% / NIACINAMIDE 4%- metronidazole 1% / niacinamide 4% gel 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

METRONIDAZOLE 1% / NIACINAMIDE 4%

Directions for use

ff

Sincerus Florida, LLC

d

Active, inactive

vv

NDC 72934- 1145-2 METRONIDAZOLE USP 1% / NIACINAMIDE USP 4%. Gel 30gm

s

METRONIDAZOLE 1% / NIACINAMIDE 4% 
metronidazole 1% / niacinamide 4% gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1145
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
METRONIDAZOLE (UNII: 140QMO216E) (METRONIDAZOLE - UNII:140QMO216E) METRONIDAZOLE1 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Product Characteristics
Colorwhite (CLEAR GEL) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-1145-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/16/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/16/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-1145)

Revised: 5/2019
Document Id: 88ef02eb-8273-b175-e053-2995a90a5a2f
Set id: 88ef02eb-8272-b175-e053-2995a90a5a2f
Version: 1
Effective Time: 20190515
 
Sincerus Florida, LLC